REFERENCES
- Saarinen UM, Hovi L, Riikonen P, Pihkala J, Juvonen E. Recombinant human granulocyte-macrophage colony-stimulating factor in children with chemotherapy induced neu-tropenia. Med Ped Oncol 1992; 20: 489–496.
- Steward VITP, Scarffe JH. Clinical trials with hematopoietic growth factors. Progr Growth Factor Res 1989;1, 1: 1–12.
- Smith T. Successful use of GM-CSF in patients with acute lymphocytic leukemia. Am J Med 1990; 89, 2: 384–385.
- Steward WP. Granulocyte and granulocyte-macrophage colony-stimulating factors. Lancet 1993; 342: 153–156.
- Lieschke GJ, Burgess AW. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N Engl J Med 1992; 327, 2: 99–106.
- Furman WL, Fairclough DL, Huhn RD, et al. Therapeutic effects and pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in childhood cancer patients receiving myelosuppressive chemotherapy. J Clin Oncol 1991; 9, 6: 1022–1028.
- Hathaway WE, Hays T. Hypercoagulability in child-hood cancer. J Pediatr Surg 1975; 10, 6: 893–899.
- McComb RD. Heterogeneous expression of factor VIII/von Willebrand factor by cardiac myxoma cells. Am J Surg Pathol. 1984; 8, 7: 539–544.
- Nemeth AJ, Penneys NS. F XIII. is expressed by fibrob-lasts in fibrovascular tumors. J Cutan Pathol 1989; 16, 1: 266–271.